Synovial and peripheral blood CD4+FoxP3+ T cells in spondyloarthritis

Journal of Rheumatology

Volumn 38, Issue 11, 2011, Pages 2445-2451

  Appel, Heiner ^a   Wu, Peihua ^a,b   Scheer, Rebecca ^a   Kedor, Claudia ^a   Sawitzki, Birgit ^a   Thiel, Andreas ^b   Radbruch, Andreas ^b   Sieper, Joachim ^a,b   Syrbe, Uta ^a,b  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b DEUTSCHES RHEUMA FORSCHUNGSZENTRUM   (Germany)

Author keywords

FOXP3; Joint inflammation; Spondyloarthritis; Treg

Indexed keywords

CD4 ANTIGEN; DISEASE MODIFYING ANTIRHEUMATIC DRUG; INTERLEUKIN 2 RECEPTOR ALPHA; INTERLEUKIN 7 RECEPTOR; METHOTREXATE; NONSTEROID ANTIINFLAMMATORY AGENT; PREDNISOLONE; TRANSCRIPTION FACTOR FOXP3; TUMOR NECROSIS FACTOR INHIBITOR;

ADULT; ANKYLOSING SPONDYLITIS; ARTICLE; BLOOD; CONTROLLED STUDY; CROHN DISEASE; CYTOKINE PRODUCTION; DEMETHYLATION; FLOW CYTOMETRY; HUMAN; MAJOR CLINICAL STUDY; METHYLATION; PHENOTYPE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PSORIATIC ARTHRITIS; QUANTITATIVE ANALYSIS; REACTIVE ARTHRITIS; REGULATORY MECHANISM; REGULATORY T LYMPHOCYTE; RHEUMATOID ARTHRITIS; SYNOVIAL FLUID;

ADULT; AGED; ANTIGENS, CD4; ARTHRITIS, PSORIATIC; ARTHRITIS, REACTIVE; ARTHRITIS, RHEUMATOID; BLOOD CELLS; CASE-CONTROL STUDIES; CELL COUNT; CYTOKINES; FORKHEAD TRANSCRIPTION FACTORS; HUMANS; INTERLEUKIN-2 RECEPTOR ALPHA SUBUNIT; INTERLEUKIN-7 RECEPTOR ALPHA SUBUNIT; MIDDLE AGED; PHENOTYPE; SPONDYLARTHRITIS; SPONDYLITIS, ANKYLOSING; SYNOVIAL FLUID; T-LYMPHOCYTES; T-LYMPHOCYTES, REGULATORY;

EID: 80155126034     PISSN: 0315162X     EISSN: 14992752     Source Type: Journal    
DOI: 10.3899/jrheum.110377     Document Type: Article

References (22)

1. Braun J, Sieper J. Ankylosing spondylitis. Lancet 2007;369:1379-90. (Pubitemid 46590387)
2. Sieper J, Rudwaleit M, Khan MA, Braun J. Concepts and epidemiology of spondyloarthritis. Best Pract Res Clin Rheumatol 2006;20:401-17. (Pubitemid 43843063)
3. Sieper J, Appel H, Braun J, Rudwaleit M. Critical appraisal of assessment of structural damage in ankylosing spondylitis: implications for treatment outcomes. Arthritis Rheum 2008;58:649-56. (Pubitemid 351364862)
4. Sakaguchi S. Naturally arising CD4+ regulatory t cells for immunologic self-tolerance and negative control of immune responses. Annu Rev Immunol 2004;22:531-62. (Pubitemid 38680433)
5. Bennett CL, Christie J, Ramsdell F, Brunkow ME, Ferguson PJ, Whitesell L, et al. The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3. Nat Genet 2001;27:20-1. (Pubitemid 32044513)
6. Williams LM, Rudensky AY. Maintenance of the Foxp3-dependent developmental program in mature regulatory T cells requires continued expression of Foxp3. Nat Immunol 2007;8:277-84. (Pubitemid 46745377)
7. Brunkow ME, Jeffery EW, Hjerrild KA, Paeper B, Clark LB, Yasayko SA, et al. Disruption of a new forkhead/winged-helix protein, scurfin, results in the fatal lymphoproliferative disorder of the scurfy mouse. Nat Genet 2001;27:68-73. (Pubitemid 32044521)
8. Sakaguchi S. Regulatory T cells: key controllers of immunologic self-tolerance. Cell 2000;101:455-8.
9. Thiel A, Radbruch A. Antigen-specific cytometry. Arthritis Res 1999;1:25-9. (Pubitemid 32223663)
10. Wieczorek G, Asemissen A, Model F, Turbachova I, Floess S, Liebenberg V, et al. Quantitative DNA methylation analysis of FOXP3 as a new method for counting regulatory T cells in peripheral blood and solid tissue. Cancer Res 2009;69:599-608.
11. Liu W, Putnam AL, Xu-Yu Z, Szot GL, Lee MR, Zhu S, et al. CD127 expression inversely correlates with FoxP3 and suppressive function of human CD4+ T reg cells. J Exp Med 2006;203:1701-11. (Pubitemid 44036276)
12. Seddiki N, Santner-Nanan B, Martinson J, Zaunders J, Sasson S, Landay A, et al. Expression of interleukin (IL)-2 and IL-7 receptors discriminates between human regulatory and activated T cells. J Exp Med 2006;203:1693-700. (Pubitemid 44036275)
13. Huehn J, Polansky JK, Hamann A. Epigenetic control of FOXP3 expression: the key to a stable regulatory T-cell lineage? Nat Rev Immunol 2009;9:83-9.
14. Wei S, Kryczek I, Zou W. Regulatory T-cell compartmentalization and trafficking. Blood 2006;108:426-31. (Pubitemid 44061338)
15. Mottonen M, Heikkinen J, Mustonen L, Isomaki P, Luukkainen R, Lassila O. CD4+ CD25+ T cells with the phenotypic and functional characteristics of regulatory T cells are enriched in the synovial fluid of patients with rheumatoid arthritis. Clin Exp Immunol 2005;140:360-7. (Pubitemid 40559165)
16. Jiao Z, Wang W, Jia R, Li J, You H, Chen L, et al. Accumulation of FoxP3-expressing CD4+CD25+ T cells with distinct chemokine receptors in synovial fluid of patients with active rheumatoid arthritis. Scand J Rheumatol 2007;36:428-33. (Pubitemid 350293524)
17. van Amelsfort JM, Jacobs KM, Bijlsma JW, Lafeber FP, Taams LS. CD4(+)CD25(+) regulatory T cells in rheumatoid arthritis: differences in the presence, phenotype, and function between peripheral blood and synovial fluid. Arthritis Rheum 2004;50:2775-85. (Pubitemid 39209514)
18. Thornton AM, Shevach EM. CD4+CD25+ immunoregulatory T cells suppress polyclonal T cell activation in vitro by inhibiting interleukin 2 production. J Exp Med 1998;188:287-96. (Pubitemid 28357757)
19. Siegmund K, Feuerer M, Siewert C, Ghani S, Haubold U, Dankof A, et al. Migration matters: regulatory T-cell compartmentalization determines suppressive activity in vivo. Blood 2005;106:3097-104. (Pubitemid 41565906)
20. Feuerer M, Shen Y, Littman DR, Benoist C, Mathis D. How punctual ablation of regulatory T cells unleashes an autoimmune lesion within the pancreatic islets. Immunity 2009;31:654-64.
21. Prakken BJ, Samodal R, Le TD, Giannoni F, Yung GP, Scavulli J, et al. Epitope-specific immunotherapy induces immune deviation of proinflammatory T cells in rheumatoid arthritis. Proc Natl Acad Sci USA 2004;101:4228-33. (Pubitemid 38405911)
22. Zaiss MM, Frey B, Hess A, Zwerina J, Luther J, Nimmerjahn F, et al. Regulatory T cells protect from local and systemic bone destruction in arthritis. J Immunol 2010;184:7238-46.